ProSolv CardioVascular's latest release, ProSolv CardioVascular version 4.0, features the integration of FujiFilm�s radiology PACS application, Synapse with ProSolv CardioVascular to give ProSolv users access to all Synapse radiology data from one workstation, with a single sign-on and familiar user interface. This will allow Synapse users to access ProSolv�s industry leading Cardiovascular Image and Information System (CVIIS) within the Synapse application.

GE Healthcare's redesigned Centricity Cardiology suite presents a three-tiered solution aimed to provide total simplicity in management cardiac IT. MacLab Administrator, Centricity Cardiology Lab Manager and Centricity CVIS work together to give administrators, physicians and IT managers the tools to ensure accuracy and optimize clinical workflow.

In addition, Centricity Cardiology offers end-to-end automatic export to the ICD registry, the official database for Medicare patients, in which participation is mandatory for reimbursement eligibility.

Feb 2008

February 11, 2008 - Leman Cardiovascular’s animal studies to evaluate the performance in both the aortic and mitral positions of its heart valve resulted in energy loss in blood cardiac throughput and a 100 percent survival rate at 90 days, an approach that may rival stented valves.

February 11, 2008 - The American Society of Echocardiography (ASE) has issued a new consensus statement for interpreting and responding to results of a carotid ultrasound study for cardiovascular disease risk assessment, in order to identify hidden risks for heart disease without invasive procedures.

February 11, 2008 - Having a heart attack is apparently not sufficient reason for most people to change to a heart-healthy diet, a new study finds.

"We found that diet quality is poor after a coronary heart disease event," said study author Yunsheng Ma, M.D., an assistant professor of medicine at the University of Massachusetts Medical School, in Worcester.

February 11, 2008 - The first patient was successfully treated in AtriCure’s ABLATE clinical trial designed to evaluate the safety and effectiveness of AtriCure’s Isolator Synergy bipolar ablation system for reestablishing normal heart rhythm in patients with permanent atrial fibrillation or requiring concomitant open-heart surgery utilizing the Cox Maze IV procedure.

February 11, 2008 - The first patient has enrolled in the PROENCY (PROMUS, Endeavor and Cypher) European registry, Boston Scientific’s new clinical designed to observe different 'Olimus'-eluting coronary stents with the aim of helping physicians in making appropriate stent choices.

February 11, 2008 – Medrad Inc. today said it entered into a definitive merger agreement to acquire Possis Medical Inc., which in combination will offer a broader, more comprehensive suite of products to the cardiovascular intervention field.

February 11, 2008 - Boston Scientific Corp. today announced that the first patient has been enrolled in its PROENCY (PROMUS, ENdeavor and CYpher) European registry, a registry designed to observe different “Olimus”-eluting coronary stents.

February 11, 2008 – A new minimally invasive vascular occlusion device designed to close a patent ductus arteriosus (PDA) received European CE Mark approval.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now